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Introduction
The distinct functions of the GAD65 and GAD67 isoforms have 
mainly emerged from studies of knockout mice. Ablation of 
GAD67 results in >90% reduction in basal -amino butyric acid 
(GABA) levels in the brain, a cleft palate, and neonatal lethality 
(Asada et al., 1997; Condie et al., 1997). Conditional knock-
down of GAD67 in the brain has revealed the role of GABA, 
generated by this isoform, in development of neuronal circuits 
in the visual cortex (Chattopadhyaya et al., 2007). In contrast, 
GABA synthesized by GAD65 is not required for development 
and early survival but is critical for fast modulation of inhibitory 
neurotransmission in response to an increase in demand. Thus, 
GAD65/ mice show no obvious developmental abnormalities 
but are prone to epileptic seizures (Asada et al., 1996; Kash 
et al., 1997) and increased anxiety (Kash et al., 1999), and have 
defects in handling of environmental stimuli, including light and 
stress (Hensch et al., 1998; Stork et al., 2000, 2003; Shimura 
et al., 2004). The evidence from GAD67/ and GAD65/ mice 
is consistent with GAD67 providing the magnitude of basal 
firing of GABA for inhibitory neurotransmission, whereas tran-
siently activated GAD65 synthesizes GABA for high-frequency 
bursts to fine-tune GABAergic synaptic function (Tian et al., 
1999; Patel et al., 2006).
The GAD67 and GAD65 genes are derived from a com-
mon precursor and share extensive homology in the middle 
and C-terminal domains. However, they differ significantly in 
the N-terminal region, with only 22% identity in exons 1–3 
(aa 1–95 in GAD65 and 1–101 in GAD67; Bu et al., 1992). 
The crystal structure of N-terminal truncations of GAD67 
and GAD65 has revealed extensive similarities in the three-
dimensional structure of the middle and C-terminal domains 
(aa 84–585 in GAD65, 90–593 in GAD67; Fenalti et al., 2007). 
There is, however, a striking difference in the structure of the 
catalytic loop of the two isoforms (Fenalti et al., 2007), which 
is consistent with a stable binding of the coenzyme pyridoxal 
5-phosphate (PLP) to GAD67, whereas GAD65 oscillates 
between an inactive apoenzyme and an active holoenzyme 
(Battaglioli et al., 2003). The diverse N-terminal regions of GAD65 
and GAD67 share no homology with known proteins, and the 
crystal structures are not available. In GAD65, the N-terminal 
region harbors three trafficking signals that mediate targeting to 
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produces >90% of GABA in the central nervous system, 
GAD65  is  transiently  activated  and  augments  GABA 
levels  for rapid modulation of  inhibitory neurotransmis-
sion. Hydrophobic lipid modifications of the GAD65 pro-
tein  target  it  to Golgi membranes and synaptic vesicles 
in  neuroendocrine  cells.  In  contrast,  the GAD67 pro-
tein remains hydrophilic but has been shown to acquire 
membrane association by heterodimerization with GAD65. 
Here, we identify a second mechanism that mediates ro-
bust  membrane  anchoring,  axonal  targeting,  and  pre-
synaptic clustering of GAD67 but that is independent of 
GAD65. This mechanism is abolished by a leucine-103 
to  proline mutation  that  changes  the  conformation  of 
the N-terminal domain but does not affect  the GAD65- 
dependent membrane anchoring of GAD67. Thus two dis-
tinct mechanisms  target  the constitutively active GAD67 
to presynaptic clusters to facilitate accumulation of GABA 
for rapid delivery into synapses.
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its targeting. We first analyzed the subcellular localization of en-
dogenous rat GAD67 in primary hippocampal neurons. Endog-
enous rat GAD67 and GAD65 were immunolabeled with the 
K2 rabbit antibody and the GAD6 monoclonal antibody, re-
spectively. These antibodies were shown to be specific for each 
isoform in immunofluorescence experiments (Fig. S1). Confocal 
immunofluorescence analyses revealed that endogenous GAD67 
in rat neurons was localized primarily in the Golgi compartment 
and in puncta in axons, where it showed a complete colocaliza-
tion with endogenous GAD65. These GAD67/GAD65-positive 
puncta were also positive for the synaptic vesicle marker syn-
aptophysin and were therefore identified as presynaptic clusters 
(Fig. 1). The mean total number of GAD67 containing presyn-
aptic clusters was 211.80 ± 5.39 per neuron (mean ± SE; n = 4), 
which was the same as the number obtained for rat GAD65. This 
is similar to the number obtained for rat GAD65 in neuronal 
cultures of similar density in an earlier study (Kanaani et al., 
2002). GAD67 and GAD65 also localized to similar domains in 
the Golgi compartment (unpublished data). Because GAD67 is 
coexpressed with GAD65 in GABAergic neurons, these experi-
ments did not reveal whether GAD65 is critical for membrane 
anchoring of GAD67. To assess whether GAD67-GFP can be 
targeted to Golgi and presynaptic membranes in neurons in-
dependent of GAD65, primary rat hippocampal neurons were 
singly transfected with mouse, rat, or human GAD67-GFP and 
immunolabeled for endogenous GAD65 (with the GAD65- 
specific human monoclonal antibodies MICA2, -3, and -6), GFP, 
and for either the Golgi marker Golgi matrix protein of 130 kD 
(GM130) or synaptophysin. Because only 5–10% of neurons in 
primary hippocampal cultures are GABAergic, the majority of 
transfected neurons are non-GABAergic and devoid of endog-
enous GAD65. Confocal analyses of these experiments showed 
that recombinant mouse and human GAD67-GFP are targeted 
to Golgi membranes, somatic vesicles, and presynaptic clus-
ters in nerve terminals in neurons that lack endogenous GAD65 
(non-GABA ergic neurons, negative for GAD65; Figs. 2 and 3).
 Quantitative analyses of GAD65-negative neurons transfected 
with GAD67-GFP revealed a mean total number of presynap-
tic clusters of 206.2 ± 10.9 (mean ± SE; n = 7) per neuron for 
the mouse GAD67-GFP protein and 211.2 ± 7.9 (mean ± SE; 
n = 5) per neuron for the human GAD67-GFP protein, respec-
tively, which is similar to the number of presynaptic clusters 
positive for endogenous GAD67 in GABAergic rat neurons 
expressing GAD65 (see above in this paragraph). Thus, the 
absence of GAD65 in transfected neurons did not seem to nega-
tively impact the number of presynaptic clusters targeted by 
GAD67-GFP. Similar transfection experiments using a recom-
binant rat GAD67-GFP clone were, however, dichotomous. This 
protein was diffuse in the soma, dendrites, and axons, and failed 
to associate with membrane compartments in the absence of en-
dogenous GAD65 (Fig. 4 A). Sequencing of all three GAD65-
GFP cDNA constructs revealed a nucleotide difference in the 
rat GAD67-GFP cDNA and in the original Bluescript clone it 
was derived from that had resulted in a proline in position 102 
instead of the original leucine, and a second nucleotide differ-
ence resulting in leucine in position 473 instead of a valine. 
No changes from published sequences were found in mouse and 
Golgi membranes and post-Golgi trafficking to cytosolic vesicles 
in nonneuronal cells and synaptic vesicles in neuroendocrine 
cells (Kanaani et al., 2002). Both GAD67 and GAD65 are syn-
thesized as soluble hydrophilic molecules. GAD65 undergoes 
a series of posttranslational hydrophobic modifications in 
the N-terminal domain, including palmitoylation of cysteines 
30 and 45 (Christgau et al., 1991, 1992; Shi et al., 1994). In con-
trast, GAD67 remains hydrophilic (Christgau et al., 1991, 1992; 
Solimena et al., 1993, 1994; Kanaani et al., 1999). After the first 
hydrophobic modification, GAD65 is targeted to the cytosolic 
face of the ER and Golgi compartments, where it cycles on and 
off membranes until palmitoylation in Golgi membranes results 
in trafficking to the TGN and post-Golgi targeting to cytosolic 
vesicles in nonneuronal cells (Kanaani et al., 2008). In primary 
neurons, GAD65 is selectively targeted to axons and presynap-
tic clusters. Targeting of GAD65 to synaptic vesicles circum-
vents the long distance between the soma and axon termini and 
facilitates rapid filling of synaptic vesicles to sustain intense 
firing of GABAergic neurons. A dynamic palmitoylation/ 
depalmitoylation cycle continuously shuttles GAD65 between 
Golgi membranes and presynaptic clusters, revealing a sophisti-
cated mechanism for rapid regulation of the levels of enzyme and 
its product in presynaptic membranes (Kanaani et al., 2008; 
for review see Baekkeskov and Kanaani, 2009). The subcellu-
lar localization of the GAD67 isoform has remained ambiguous. 
Recombinant rat GAD67 was soluble in transfected CHO and 
COS-7 cells (Solimena et al., 1993; Dirkx et al., 1995) but was 
shown to acquire membrane association by heterodimerization 
with GAD65 (Dirkx et al., 1995; Kanaani et al., 1999). However, 
subcellular fractionation of brains and confocal analyses of neu-
rons from GAD65/ mice showed that mouse GAD67 is firmly 
membrane anchored and targets to presynaptic clusters in the ab-
sence of GAD65 and in spite of lacking intrinsic hydrophobicity 
(Kanaani et al., 1999; Obata et al., 1999). In this study, we have 
analyzed the subcellular localization and membrane anchoring 
of endogenous rat GAD67 and of transfected recombinant rat, 
mouse, and human GAD67 in neurons and nonneuronal cells. 
The studies reveal that in all three species, GAD67 is targeted 
to membranes and vesicular trafficking pathways independent 
of GAD65. The results suggest that in addition to membrane 
anchoring by heterodimerization with GAD65, which involves 
the middle- and C-terminal regions of the protein, a separate and 
similarly robust membrane-targeting mechanism, involving the 
N-terminal region, has evolved for GAD67 in neurons and sev-
eral other cell types. This distinct mechanism mediates selective 
axonal targeting and presynaptic clustering of GAD67, resulting 
in targeting similar to that of the smaller isoform GAD65, yet 
independent of it.
Results
In primary neurons, GAD67 is targeted  
to Golgi membranes, cytosolic vesicles,  
and presynaptic clusters independent  
of GAD65
We sought to clarify the contrasting reports on the membrane 
anchoring properties of GAD67 and the role of GAD65 in 
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The results show that primary neurons possess a membrane an-
choring machinery that targets mouse, rat, and human GAD67 to 
Golgi membranes and somatic vesicles in primary neurons and 
mediates robust axonal targeting and presynaptic clustering in-
dependent of GAD65, yet at an efficiency similar to that obtained 
for GAD67 in the presence of GAD65 and for GAD65 itself. 
The data are consistent with the results obtained in GAD65/ 
mice, where endogenous mouse GAD67 was shown to be firmly 
membrane anchored and targeted to presynaptic clusters in the 
absence of GAD65 (Kanaani et al., 1999; Obata et al., 1999).
Mutation of leucine 102/103 to proline 
in GAD67 abolishes GAD65-independent 
membrane anchoring of GAD67 in  
primary neurons, without affecting its 
GAD65-dependent membrane anchoring 
and subcellular targeting
The results described in the previous paragraph suggested 
that a mutation of leucine 102 to proline abolishes the ability 
of rat GAD67 to become membrane-anchored independent of 
GAD65. Leucine 102 in rat and mouse GAD67 is equivalent to 
leucine 103 in human GAD67. To further analyze the effect of 
human GAD67-GFP. Although the first change in rat GAD67 
would be expected to have a significant effect on the confor-
mation of the protein, the second change would be expected to 
have little or no effect. Consistent with this notion, engineered 
wild-type (wt) rat cDNA generated by reinstating leucine in 
position 102 and valine in position 473, as well as a version that 
had the wt leucine reinstated in position 102 but maintained 
the mutant leucine in position 473 (rat GAD67(V473L)-GFP), 
were indistinguishable in their membrane anchoring properties 
from the mouse and human GAD67 cDNAs (unpublished data). 
In Fig. 4 B and in the remainder of the manuscript, the reengi-
neered cDNA clone, with amino acids 102 and 473 both reversed 
to the authentic rat GAD67 sequence, is referred to as wt rat 
GAD67. Wt rat GAD67-GFP was similar to mouse and human 
GAD67-GFP and targeted to Golgi membranes, cytosolic vesi-
cles, and presynaptic clusters in axon termini lacking endogenous 
GAD65 (Fig. 4 B). In quantitative analysis of neurons express-
ing wt rat GAD67-GFP, the mean total number of presynaptic 
clusters containing the protein was 196.8 ± 5.4 (mean ± SE; 
n = 7) per neuron, whereas the number of clusters expressing 
rat GAD67(L102P, V473L)-GFP in neurons transfected with 
the corresponding construct was 9.6-fold lower (Fig. 4 C). 
Figure 1. Endogenous rat GAD67 is targeted to Golgi membranes and presynaptic clusters and excluded from dendrites in hippocampal neurons.  
Confocal immunofluorescence analysis of endogenous GAD67, GAD65, and synaptophysin in cultured rat hippocampal neurons at day in vitro 10. The field 
of view has many different neurons but only one (yellow arrow) is GABAergic and shows colocalization of endogenous GAD67 (A, green) and endogenous 
GAD65 (B, red) in the perinuclear compartment, and with GAD65 and synaptophysin (C, blue) in presynaptic clusters in the axon (arrowheads). Merging 
of the triple fluorescent signals results in a white color in presynaptic clusters of the GABAergic neuron (C). GAD65 and GAD67 were not detected in the 
dendrites of the GABAergic neuron (arrows). Panels on the right in C show enlarged views of the boxed region. Bars, 10 µm.
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Figure 2. Mouse GAD67-GFP is targeted to Golgi membranes, cytosolic vesicles, and presynaptic clusters in hippocampal neurons independent of endog-
enous GAD65. (A) Confocal images of a rat hippocampal neuron singly transfected with mouse GAD67-GFP and triple immunolabeled for GFP (green), 
endogenous GAD65 (red; mixture of human monoclonal antibodies MICA 2, 3, and 6), and the Golgi marker protein GM130 (blue; enlarged frame a). 
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Cotransfection of rat GAD67(L102P, V473L)-GFP with human 
GAD65-mCherry into hippocampal neurons resulted in target-
ing of the protein to Golgi membranes, cytosolic vesicles, and 
presynaptic clusters (Fig. 6). In the presence of human GAD65-
mCherry, the mean number of presynaptic clusters containing 
rat GAD67(L102P, V473L)-GFP was 226.3 ± 10.4 (mean ± SE, 
n = 5), which is 11-fold higher than the mean number of presynap-
tic clusters for the mutant protein in the absence of GAD65 (20.5 ± 
2.8; mean ± SE, n = 8; Fig. 6 E).
The number of presynaptic clusters containing rat 
GAD67(L102P, V473L)-GFP was similar to that for endogenous 
GAD67 in GABAergic neurons expressing GAD65; singly trans-
fected wt human, rat, or mouse GAD67-GFP in non-GABAergic 
neurons (see the first paragraph of the Results section); and 
wt rat GAD65-GFP (Kanaani et al., 2002). Thus, the GAD65-
dependent mechanism for membrane anchoring of GAD67 
is unaffected by the L102P mutation. The results suggest that 
each of the two mechanisms can separately mediate targeting of 
proline in this position on the GAD65-independent membrane 
anchoring mechanism of GAD67, leucine 103 in human GAD67 
and leucine 102 in mouse GAD67 were mutated to proline. 
Confocal analyses of human GAD67(L103P)-GFP and mouse 
GAD67(L102P)-GFP singly transfected into primary hippocam-
pal neurons revealed that the mutated proteins were diffuse in the 
soma, dendrites, and axons, and failed to associate with mem-
branes (Fig. 5, B and D), which confirmed the results obtained 
with rat GAD67(L102P,V473L)-GFP. Quantitative analyses of 
the presynaptic clustering of wt and mutant human and mouse 
GAD67-GFP proteins revealed an eight- to ninefold decrease in 
presynaptic clustering in the human and mouse leucine-to-
 proline mutants (Fig. 5 E). Thus, the mutation in this position 
efficiently inhibits the GAD65-independent membrane anchoring 
mechanism of GAD67 and results in a loss of polarized targeting 
to axons and presynaptic clustering in the absence of GAD65.
We next asked whether the L102P mutation affects the 
GAD65-dependent membrane anchoring mechanisms of GAD67. 
The transfected neuron is a non-GABAergic neuron devoid of endogenous GAD65. However, GAD65 is seen in axonal puncta of a neighboring GABAergic 
neuron. Transfected mouse GAD67-GFP is targeted to the Golgi compartment (enlarged frame a), vesicles in the soma (small arrowheads, enlarged frame 
in A), and axonal puncta (large arrowheads in A) in the absence of endogenous GAD65. (B) Confocal images of presynaptic clusters of a rat hippo-
campal neuron transfected with mouse GAD67-GFP. Cells were triple immunolabeled for GFP (green), endogenous GAD65 (GAD6 antibody, blue), and 
synaptophysin (red). The field of view shows the cell body of a non-GABAergic neuron (arrow labeled A) and a GABAergic neuron (arrow labeled B). 
The cell body of the transfected neuron is not in the field of view. Mouse GAD67-GFP colocalizes with synaptophysin in presynaptic clusters (arrowheads, 
enlarged frame b), which are devoid of GAD65, showing that the transfected neuron is non-GABAergic. Endogenous GAD65 colocalizes with synaptophysin 
in presynaptic clusters of the nontransfected GABAergic neuron in the same field of view (arrows, enlarged frame b). Bars, 20 µm.
 
Figure 3. Human GAD67-GFP is targeted 
to Golgi membranes, cytosolic vesicles, and 
presynaptic clusters in hippocampal neurons 
independent of endogenous GAD65. Con-
focal images of a hippocampal neuron sin-
gly transfected with wt human GAD67-GFP 
and triple immunolabeled for GFP (green), 
endogenous GAD65 (red; MICA 2, 3, and 
6 antibodies), and the Golgi marker pro-
tein GM130 (blue; enlarged frames from 
the boxed region shown on the bottom). 
Wt human GAD67-GFP is not detected 
in dendrites (arrows) but shows polarized 
targeting to axonal clusters (arrowheads) 
and targeting to the Golgi compartment 
and cytosolic vesicles (enlarged frame) in a 
neuron devoid of endogenous GAD65 (non- 
GABAergic neuron). Bars, 10 µm.
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Figure 4. Reverse mutation restoring leucine in position 102 and valine in position 473 to yield wt rat GAD67 results in anchoring to Golgi membranes 
and polarized targeting to axonal clusters in hippocampal neurons in the absence of endogenous GAD65. (A) Confocal images of a hippocampal neuron 
singly transfected with rat GAD67(L102P, V473L)-GFP and immunolabeled for GFP (green), endogenous GAD65 (red; MICA 2, 3, and 6 antibodies), 
and the Golgi marker protein GM130 (blue; enlarged frames of the boxed region). Transfected rat GAD67(L102P, V473L)-GFP shows a diffuse cytosolic, 
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GAD67 to a similar number of presynaptic clusters and that the 
presence of both mechanisms in GABAergic neurons express-
ing both isoforms does not cumulatively increase the number of 
GAD67-positive presynaptic clusters.
Molecular modeling of the L103P mutation 
reveals a change in orientation of the  
N-terminal domain but little effect on the 
downstream structure of GAD67
The results above show that the fortuitous leucine-to-proline 
mutation efficiently distinguishes the two mechanisms for 
membrane anchoring of GAD67 and selectively inhibits the 
GAD65-independent mechanism while leaving the GAD65-
dependent mechanism intact. To assess the potential structural 
changes induced by the L103P mutation in human GAD67, we 
used the Protein Data Bank crystal structure (accession no. 2OKJ) 
of the protein dimer (Fenalti et al., 2007) to computationally 
model the mutation. In the crystal structure of the human GAD67 
dimer, residues 1–92 are lacking in both monomers. However, 
the segment 93–106 is sufficiently well-defined to regard it as 
an anchor for the missing segment 1–92. Thus, any change in 
orientation of the segment 93–106 is likely to produce a sig-
nificant change in the orientation of the segment 1–92 and thus 
affect its function. The modeled mutation was performed on 
dendritic (arrows), and axonal (arrowheads) localization and fails to associate with Golgi membranes and axonal clusters in a neuron devoid of endog-
enous GAD65 (non-GABAergic neuron). GAD65 is seen in axonal clusters in a neighboring GABAergic neuron. Bars, 10 µm. (B) Confocal images of a 
hippocampal neuron singly transfected with rat GAD67-GFP converted to the wt protein (L102, V473) and immunolabeled for GFP (green), endogenous 
GAD65 (red; MICA 2, 3, and 6 antibodies), and the TGN marker protein TGN38 (blue; enlarged frame b). In contrast to the rat GAD67(L102P, V473L)-GFP 
mutant, wt rat GAD67-GFP is not detected in dendrites (arrows) but shows polarized targeting to axonal clusters (arrowheads) and targeting to the 
Golgi compartment (enlarged frame b). Bars, 10 µm. (C) Quantification of the number of presynaptic clustering of wt rat GAD67-GFP and GAD67(L102P, 
V473L)-GFP in rat hippocampal neurons shows an 10-fold difference in presynaptic clustering. Results are presented as mean ± SE (error bars) for 
5–8 neurons for each protein. *, P < 0.0001.
 
Figure 5. Mutation of leucine 103 in human 
GAD67 and leucine 102 in mouse GAD67 to 
proline abolishes GAD65-independent mem-
brane anchoring of GAD67-GFP in hippo-
campal neurons. Projected confocal images 
of hippocampal neurons singly transfected 
with either wt human GAD67-GFP (A), human 
GAD67(L103P)-GFP mutant (B), wt mouse 
GAD67-GFP (C), or mouse GAD67(L102P)-
GFP mutant (D). Neurons were immuno-
labeled for GFP (green) and endogenous 
GAD65 (red; MICA 2, 3, and 6 antibodies). 
Although the wt human as well as mouse 
proteins are polarized to presynaptic clusters 
in the axon (arrowheads) of non-GABAergic 
neurons (A and C), the mutant proteins show 
a diffuse distribution in the soma, dendrites 
(arrows), and axon (B and D, arrowheads). 
Bars, 10 µm. (E) Quantification of the number 
of presynaptic clusters of the wt and mutant 
proteins shows an eight- to ninefold decrease 
in presynaptic clustering of the L103P as well 
as L102P mutant proteins compared with the 
wt proteins. Results are presented as mean ± 
SE (error bars) for 5–7 neurons for each pro-
tein. *, P < 0.0001.
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shows the measured change in the position and reorientation of 
residue 93. It is displaced by 3.5 angstroms; and relative to resi-
due 98, which remains nearly fixed, it undergoes a reorientation 
of 19.8°. A significant reorientation of the disordered segment 
1–92 is therefore expected. Although the molecular modeling 
results are provisional because of the lack of the 1–92 segment 
in the crystal structure, they nevertheless suggest a critical role 
of the conformation of the N-terminal domain, upstream of leu-
cine 103 in human and leucine 102 in rat and mouse GAD67, 
in the GAD65-independent membrane anchoring of the protein. 
Conversely, the GAD65-dependent mechanisms for membrane 
anchoring of GAD67 appear to be unaffected by the changes 
in the conformation of the N-terminal domain that occur in 
the leucine-to-proline mutants. This is consistent with the pro-
posed role of heterodimerization of GAD67 and GAD65 in 
the anchor segment of the A monomer in the form of a reduced 
model of the crystal structure. This consisted of the six seg-
ments a93-a119, a165-a169, b195-b198, b573-b574, b132, and 
b470, in which the first contains the anchor segment extended 
by 13 residues to allow for downstream mutation effects and 
the others represent the local environment with which it directly 
interacts. As described in the Materials and methods section, 
this assembly of six segments was subjected to two identical 
energy refinements under the constraint that residues 116–119 
be held fixed. The first refinement was done without the mu-
tation to obtain a control against which measurements could 
be made that allow for reduced-model effects. In the second 
refinement, leucine 103 was replaced by a proline. Fig. S2 A 
shows the crystal structure of the human GAD67 dimer with 
the segments 93–119 highlighted in each monomer. Fig. S2 B 
Figure 6. GAD65 mediates targeting of rat GAD67(L102P, V473L)-GFP to Golgi membranes and cytosolic vesicles, as well as polarized targeting to pre-
synaptic clusters in hippocampal neurons. Confocal images of a hippocampal neuron cotransfected with rat GAD67-GFP(L102P, V473L)-GFP and human 
GAD65-mCherry, and triple immunolabeled for GFP (A, green), mCherry (B, red), and synaptophysin (C, blue). In the presence of human GAD65-mCherry, 
rat GAD67(L102P, V473L)-GFP is targeted to presynaptic clusters, where it colocalizes with human GAD65 and synaptophysin (C, arrowheads in enlarged 
frame a), Golgi membranes (D, enlarged frame b), and vesicles in the soma (D, arrowheads in enlarged frame c), where it colocalizes with human GAD65-
mCherrry. Bars, 10 µm. (E) Quantification of the number of presynaptic clusters in hippocampal neurons expressing rat GAD67(L102P, V473L)-GFP, 
either alone or with human GAD65-mCherry, shows an 11-fold increase in presynaptic clustering of the cytosolic rat GAD67(L102P, V473L)-GFP when 
coexpressed with human GAD65-mCherry. Results are presented as mean ± SE (error bars) for eight neurons expressing rat GAD67(L102P, V473L)-GFP 
and for five neurons coexpressing rat GAD67(L102P, V473L)-GFP and human GAD65-mCherry. *, P < 0.0001.
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this mechanism, which does not involve the N-terminal do-
main (Kanaani et al., 1999) and likely involves the middle and 
C-terminal domains of GAD67.
The GAD65-independent membrane 
anchoring machinery for GAD67 is 
expressed in COS-7, CHO, and MDCK cells
In earlier studies, recombinant rat GAD67 expressed in COS-7 
and CHO cells was found to be a soluble molecule (Solimena 
et al., 1993, 1994; Dirkx et al., 1995), which could only acquire 
membrane anchoring by dimerization with GAD65 (Dirkx 
et al., 1995). This is in contrast with the results presented in 
Figs. 2 and 3 showing that the GAD65-independent mechanism 
for membrane anchoring and targeting of GAD67 is functional 
in neurons. We addressed the question of whether the GAD65-
independent membrane anchoring machinery for GAD67 is 
missing in COS-7 and CHO cells. Recombinant wt mouse, rat, 
or human GAD67 and/or GAD67-GFP were singly transfected 
into COS-7, CHO, and MDCK cells. Confocal analyses of these 
experiments showed that human GAD67 (unpublished data) 
and mouse, rat, and human GAD67-GFP target to Golgi mem-
branes and cytosolic vesicles in COS-7, MDCK, and CHO cells 
(Fig. S3, A–C; Fig. S4, A, C, and E; and not depicted) simi-
lar to what we have shown for GAD65 (Kanaani et al., 2008). 
Thus, the GAD65-independent membrane anchoring mecha-
nism is present not only in primary neurons but also in COS-7, 
CHO, and MDCK cells. The earlier studies showing a soluble 
rat GAD67 in COS-7 and CHO cells in the absence of GAD65 
(Solimena et al., 1993, 1994; Dirkx et al., 1995) appear to have 
used a recombinant rat GAD67 clone derived from the same 
source as the Bluescript clone, which we have now identi-
fied as having the L102P mutation that impairs the GAD65- 
independent membrane anchoring machinery for GAD67.
The L102/103P mutation effectively 
distinguishes the GAD65-dependent 
and -independent membrane anchoring 
mechanism of GAD67 in COS-7 cells
We analyzed the effect of the L102P or L103P mutation on the 
GAD65-dependent and -independent mechanism of GAD67 
membrane anchoring and subcellular targeting in COS-7 cells. 
Mouse GAD67(L102P)-GFP, rat GAD67(L102P,V473L)-GFP, 
and human GAD67(L103P)-GFP were singly transfected into 
COS-7 cells. In contrast to the wt mouse, rat, and human GAD67-
GFP (Fig. S4, A, C, and E), the mutant proteins were diffuse in 
the cytosol (Fig. S4, B, D, and F). Quantitative analyses of the 
number of vesicles containing GAD67-GFP per 10 µm2 showed 
a 20–30-fold decrease in GAD65-independent vesicular tar-
geting of mouse and rat GAD67(L102P)-GFP and human 
GAD67(L103P)-GFP, respectively, compared with the wt 
mouse, rat, and human proteins (Fig. S4 G).
We addressed the possibility that the leucine-to-proline 
mutation renders GAD67-GFP susceptible to proteolytic cleav-
age in cells lacking GAD65, such that the observed diffuse 
staining represents free GFP rather than the GAD67 protein. 
Rat GAD67(L102P) lacking the GFP tag and GFP-tagged rat 
GAD67(L102P) were singly transfected into MDCK cells, and 
immunostained with an antibody to GAD67 or with an antibody 
to GFP. Confocal analyses revealed a similar diffuse pattern of 
immunostaining for GAD67(L102P) lacking the GFP tag com-
pared with the GFP tag (unpublished data). Furthermore, SDS-
PAGE analyses and immunoblotting of wt and mutant human, 
mouse, and rat GAD67-GFP proteins expressed in COS-7 cells 
revealed only the full-length fusion proteins with either the 1701 
antibody or an anti-GFP antibody (unpublished data). Thus, the 
solubility observed for the human, mouse, and rat GAD67 
leucine-to-proline mutants is a property of the proteins them-
selves and not of cleaved GFP.
Cotransfection of the membrane anchoring–deficient rat 
GAD67(L102P, V473L)-GFP mutant with either rat GAD65 
or human GAD65-mCherry resulted in targeting of the pro-
tein to Golgi membranes and cytosolic vesicles in COS-7 cells 
(Fig. S5, B and C). Quantitative analyses revealed that in the 
presence of rat GAD65 or human GAD65-mCherry, targeting 
of rat GAD67(L102P, V473L)-GFP to cytosolic vesicles was 
similar to that of wt human, rat, and mouse GAD67-GFP, and 
of human GAD65 expressed alone in COS-7 cells (Fig. S5 D). 
In conclusion and similar to the results in neurons, the L103P mu-
tation in human GAD67 and the L102P mutation in the mouse 
and rat proteins efficiently inhibit the GAD65-independent 
mechanism for membrane anchoring and subcellular targeting 
of GAD67 in COS-7 cells while leaving the GAD65-dependent 
targeting mechanism intact.
The GAD65-independent membrane 
anchoring of GAD67 results in distribution 
of recombinant GAD67 between membrane 
and soluble fractions in COS-7 cells, which 
is similar to that of GAD65
Isolation of the GAD65 isoform from brain or from transfected 
cells reveals a pool of protein with weak membrane affinity, 
which is easily displaced from membranes, and a pool that is 
firmly membrane anchored and can only be released from 
membranes by detergent. The first pool represents nonpalmi-
toylated GAD65 that cycles on and off ER and Golgi membranes 
before targeting to TGN after palmitoylation. In subcellular 
fractionation experiments in COS-7 cells, the hydrophobic but 
nonpalmitoylated pool of GAD65 is released from membranes 
during homogenization in 1 mM MgCl2 and a wash of micro-
somal membrane fractions in 0.5 M NaCl. Approximately 50% 
of the protein is, however, firmly membrane bound and can only 
be released from membranes by detergent (Fig. 7; Christgau 
et al., 1991; Shi et al., 1994). We analyzed the distribution of 
recombinant mouse and human GAD67 between cytosolic and 
membrane compartments in COS-7 cells in the absence of 
GAD65. Cytosol and membrane fractions, washed in high salt, 
were prepared from singly transfected cells and subjected to 
SDS-PAGE, followed by Western blotting and immunostain-
ing with the 1701 antibody, which recognizes both GAD65 and 
GAD67. The rat GAD67(L102P, V473L) variant as well as wt 
and soluble mutants of GAD65 were analyzed for comparison. 
The subcellular analyses showed that similar to human GAD65, 
50% of singly transfected wt human and mouse GAD67, 
respectively, were detected in the washed membrane fractions 
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(Fig. 7 B and not depicted). Thus, about half of human 
GAD67 and mouse GAD67 is firmly membrane anchored in 
COS-7 cells and can only be released from membranes by de-
tergent. In contrast, >90% of the rat GAD67(L102P, V473L) 
variant is present in the cytosolic fraction, which is similar to 
the distribution of soluble mutants of human and rat GAD65 
(human GAD65/24-31A and rat GAD65/45A1-38, respec-
tively; Fig. 7). Those results suggest that similar to GAD65 
(Christgau et al., 1992; Shi et al., 1994; Kanaani et al., 1999, 
2002), approximately half of GAD67 has a low membrane avidity 
and can be released from membranes by a salt wash, whereas 
the remaining half of the protein is firmly membrane anchored. 
Thus, the GAD65-independent membrane anchoring mecha-
nism for GAD67 results in membrane association properties 
similar to those of GAD65 itself.
Discussion
The results presented here reveal that the hydrophilic GAD67 
isoform is anchored to membranes and targeted to the Golgi 
compartment and presynaptic clusters by two different mecha-
nisms. One mechanism, which has been described previously 
(Dirkx et al., 1995; Kanaani et al., 1999), involves association 
of GAD67 with the hydrophobic GAD65 isoform in a hetero-
dimeric conformation. The resultant targeting of the GAD67 
subunit to membrane compartments is likely mediated by the 
intrinsic membrane-targeting signals in GAD65. Association 
with GAD65 is, however, not the sole mechanism for membrane 
anchoring and targeting of GAD67. Rather, the results shown 
here reveal that GAD67 possesses an independent capability 
for membrane anchoring that mediates robust targeting to Golgi 
membranes, vesicular pathways, axons, and presynaptic clusters. 
Thus, both GAD65-dependent and GAD65-independent mech-
anisms mediate targeting of GAD67 to Golgi membranes and 
polarized localization to axons and presynaptic clusters. We pro-
pose that the GAD65-independent mechanism likely involves as-
sociation with a different protein, a complex of several proteins, 
or a protein–lipid complex, a postulate based on the demonstra-
tion that GAD67 extracted from membrane fractions prepared 
from the brain of GAD65/ mice is a hydrophilic molecule de-
void of intrinsic hydrophobic moieties (Kanaani et al., 1999). 
A mutation changing leucine 102 to proline in recombinant rat and 
mouse GAD67 and the corresponding leucine 103 to proline in 
human GAD67 abolishes the GAD65-independent mechanisms, 
and has enabled separate analyses of the two mechanisms.
In the absence of GAD65, the distribution of GAD67 
between firmly membrane-bound and weak membrane affinity 
pools is similar to that of GAD65, which suggests that the mem-
brane anchoring properties achieved by the GAD65-independent 
method closely mimic those of GAD65 itself. Furthermore, 
in a separate study, we have shown that polarized targeting of 
mouse GAD67 to presynaptic clusters in the absence of GAD65 
follows an axon-specific Rab5a-dependent trafficking pathway 
Figure 7. GAD65-independent membrane anchoring of GAD67 re-
sults in distribution of GAD67 between soluble and firmly membrane- 
anchored pools similar to human GAD65. (A) Analysis of the subcel-
lular distribution of recombinant GAD67 and GAD65, which lacked a 
GFP tag expressed in COS-7 cells. COS-7 cells expressing individual 
GAD67 and GAD65 proteins were subjected to subcellular fraction-
ation. Cytosolic proteins (lane 1), proteins washed from membranes by 
high salt (lanes 2 and 3), and detergent-extracted membrane proteins 
(lane 4) were subjected to SDS-PAGE and immunoblotting with the 1701 
antibody, which recognizes both GAD65 and GAD67. Recombinant 
human and mouse GAD67 are primarily detected in the washed mem-
brane fraction similar to human and rat GAD65. Rat GAD67(L102P, 
V473L), however, is primarily detected in the cytosol fraction similar 
to the soluble mutants hGAD65/24-31A and rGAD65/45A1-38. 
Each experiment was performed two to three times with similar results. 
(B) Quantitative analysis of the subcellular distribution of human GAD65 
and GAD67 in COS-7 cells. COS-7 cells expressing human GAD65 
or GAD67 were subjected to subcellular fractionation followed by 
SDS-PAGE and immunoblotting. Quantitation of immunoblots of three 
independent experiments was performed using NIH Image software. 
GAD immunoreactivity in each fraction is expressed as the percentage 
of total GAD. Data are represented as mean value ± SD (error bars). 
Human GAD67 and GAD65 show similar subcellular distribution in 
COS-7 cells, with 48.4 ± 1.0% and 52.4 ± 6.5% of hGAD65 and hGAD67, 
respectively, being firmly membrane bound and only released from mem-
branes by detergent.
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apoenzyme in Golgi membranes that then becomes activated 
by infusion of PLP once it has reached a presynaptic location. 
The constitutively active GAD67, in contrast, likely produces 
GABA not only on synaptic vesicle membranes, but also on the 
cytosolic face of Golgi membranes and somatic vesicle mem-
branes. In fact, during development, GABA is generated in the 
soma by GAD67 and secreted from immature neurons before the 
maturing of synaptic vesicles (Owens and Kriegstein, 2002a,b), 
reflecting its roles in shaping of the central nervous system 
(Wang and Kriegstein, 2009). The cycling of constitutively 
active GAD67 between presynaptic clusters, where GABA can 
be rapidly deposited into synaptic vesicles, and the soma, where 
GABA may either be used as a metabolite and directed to the 
GABA shunt for energy production (Soghomonian and Martin, 
1998) or released by a nonvesicular mechanism, may facilitate 
dynamic variation in its subcellular localization to variably pro-
duce GABA for these distinctive purposes.
A rationale for supplying  
GAD67 to synaptic vesicles by  
two distinct mechanisms
Although the GAD65-dependent and -independent mechanisms 
of membrane anchoring and intracellular trafficking of GAD67 
both target the protein to Golgi membranes, vesicular pathways, 
and presynaptic clusters, they are likely to serve different roles. 
As depicted in Fig. 8, it is possible that the GAD65-independent 
trafficking route for delivering GAD67 supplies the constitutive 
reservoir of glutamic acid decarboxylase (GAD) activity for GABA 
synthesis. Two distinct functions can, however, be suggested for 
the GAD65-dependent membrane anchoring of GAD67. First, 
because GAD65 associates with the vesicular GABA transporter 
on the cytosolic face of synaptic vesicles (Jin et al., 2003), it is 
possible that piggybacking of GAD67 enables delivery of GABA 
synthesized by this isoform to the vesicular GABA-transporter, 
thereby facilitating a rapid accumulation of GABA in synaptic 
vesicles. Second, the formation of GAD67-GAD65 heterodimers 
on synaptic vesicle membranes may serve a role in mediating 
retrograde transport of GAD67 to Golgi membranes, and thus en-
able dynamic cycling (and consequent modulation of activity) of 
this otherwise constitutively activated isoform. This is governed 
by the depalmitoylation/repalmitoylation cycle that regulates the 
subcellular distribution of its piggyback transporter GAD65. 
Thus, GAD65/GAD67 heterodimerization may increase the ca-
pacity for GABA synthesis that is regulated by conditional shut-
tling of the GAD enzymes between the Golgi compartment and 
synaptic vesicles. As shown in Fig. 8, two distinct GAD67 dimers 
with different regulatory properties can then reach presynaptic 
clusters: (1) the constitutively active GAD67 homodimer, which 
is a stable holoenzyme, provides the basal GABA level, and (2) 
the GAD65/GAD67 heterodimer, consisting of one subunit of 
constitutively active GAD67 and one subunit of conditionally 
active GAD65 (transiently activated by an influx of the coenzyme 
PLP). A third dimer, the GAD65 homodimer (not shown in 
Fig. 8), is similarly conditionally regulated by PLP levels. The 
GAD65 homo- and GAD65/GAD67 heterodimers can cycle 
between Golgi and synaptic vesicles and contain conditionally 
active or inactive GAD65 apoenzyme, thereby providing for a 
(unpublished data), first identified for GAD65 (Kanaani et al., 
2004). In summation, GAD67 undergoes polarized targeting to 
axons and reaches its functionally critical location in presynaptic 
clusters by two distinct mechanisms that each deliver GAD67 to 
the same subcellular destinations and with similar efficiency: one 
route is GAD65 independent, whereas the second involves binding 
to GAD65 to piggyback and exploit its intracellular trafficking.
Targeting domains of GAD67
The GAD65-dependent and -independent mechanisms of mem-
brane anchoring of GAD67 appear to be mediated by distinct 
domains of GAD67. The GAD65 and GAD67 isoforms self-
assemble as nondisulfide linked homodimers via interactions 
between the middle and C-terminal domains of each monomer, 
whereas their N-terminal domains are not involved in dimeriza-
tion (Schwartz et al., 1999; Capitani et al., 2005; Fenalti et al., 
2007). The three-dimensional structure of the heterodimer be-
tween GAD65 and GAD67 is not available. By analogy with 
the structure of the GAD65 and GAD67 homodimers (Schwartz 
et al., 1999; Capitani et al., 2005; Fenalti et al., 2007), and given 
the high degree of homology between GAD65 and GAD67 in 
the dimer interfaces, heterodimerization of GAD65 and GAD67 
is likely to similarly involve the middle and C-terminal domains 
of both proteins. As for the N-terminal region, the data presented 
here suggest that this region of GAD67 is specifically required 
for the GAD65-independent trafficking and subcellular localiza-
tion of GAD67. Thus, the L103P mutation in the N-terminal re-
gion of human GAD67 and the corresponding L102P mutation 
in murine GAD67 disrupt the GAD65-independent membrane 
association, without affecting GAD65-dependent localization, 
thereby clearly separating the two trafficking mechanisms and 
associating them with distinct structural domains of the protein. Spe-
cifically, the data suggest a critical involvement of the N-terminal 
region in the GAD65-independent pathway.
GAD67 and GAD65 in Golgi membranes
The Golgi compartment appears to be a depot for newly synthe-
sized GAD65 and GAD67 en route to synaptic clusters. In the 
case of GAD65, a depalmitoylation step likely performed by 
one of the acylprotein thioesterases identified in synaptic ves-
icles (Kim et al., 2008) or in the cytosol (Duncan and Gilman, 
1998), releases GAD65 from peripheral membranes and results 
in its retrograde trafficking back to Golgi membranes by a non-
vesicular pathway. Depalmitoylated GAD65 cycles on and off 
the cytosolic face of Golgi membranes until repalmitoylation 
by a palmitoyl transferase in Golgi membranes targets it to the 
TGN, initiating a new cycle of vesicular trafficking to synaptic 
termini (Kanaani et al., 2008; for review see Baekkeskov and 
Kanaani, 2009). This dynamic cycling of GAD65 between post-
Golgi and Golgi pools demonstrably enables a neuron to rapidly 
regulate the levels of the enzyme in presynaptic terminals. But 
does the heterodimerization of GAD67 with GAD65 result in 
a similar dynamic cycling of the larger isoform between Golgi 
and post-Golgi membranes? And is there a functional role for 
both GAD65 and GAD67 in the Golgi compartment? It is un-
known whether the transiently active GAD65 is a holoenzyme in 
both Golgi and presynaptic terminals or whether it is an inactive 
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Figure 8. Schematic model of GABA production. Homodimers of the constitutively active GAD67 traffic from the TGN to synaptic vesicles via a GAD65-
independent mechanism to produce basal levels of GABA. Heterodimers of constitutively active GAD67 and GAD65 (transiently activated by influx of 
PLP) dynamically cycle back and forth between the TGN and synaptic vesicles, as mediated by the palmitoylation/depalmitoylation cycle of GAD65, to 
modulate the levels of GABA production and episodically fine-tune GABAergic signaling. Not shown is the GAD65 homodimer, which similarly oscillates 
between TGN and synaptic vesicles and is dependent on PLP for activation.
means to transiently increase GABA levels so as to fine-tune 
inhibitory neurotransmission. We envision that the GAD65-
independent trafficking of GAD67 serves a distinct and equally 
important role of producing the core levels of GABA used in 
synaptic transmission.
Materials and methods
Antibodies
The 1701 rabbit antiserum, which recognizes GAD65 and GAD67 equally 
well on Western blots (Kim et al., 1993), and a mouse monoclonal antibody 
to GFP (Covance) were used in immunoblotting and immunofluorescence 
experiments. The following primary antibodies were used in immunofluores-
cence experiments: chicken polyclonal antibody raised to purified 6-his–
tagged GFP (Millipore); GAD6, a mouse monoclonal antibody specific 
for GAD65 (Chang and Gottlieb, 1988); a mixture of GAD65-specific 
human monoclonal antibodies MICA 2, 3, and 6, derived from an islet cell 
antibody-positive patient (a gift from W. Richter, University of Heidelberg, 
Heidelberg, Germany; Richter, et al., 1993); K2 rabbit antiserum, which 
primarily recognizes GAD67 on Western blots (Millipore); mouse mono-
clonal antibody to the GM130 (BD); mouse monoclonal antibody to the TGN 
marker protein TGN38 (BD); rabbit polyclonal antibody to synaptophysin 
(Invitrogen); mouse monoclonal antibody to synaptophysin (Sigma-Aldrich); 
and Living Colors DsRed rabbit polyclonal antibody raised against DsRed-
Express that recognizes mCherry (Takara Bio Inc.). The following secondary 
antibodies were used in immunofluorescence experiments: Cy3-conjugated 
AffiniPure donkey anti–mouse, rabbit, or human IgG (Jackson Immuno-
Research Laboratories, Inc.), Alexa Fluor 350 goat anti–mouse IgG, Alexa 
Fluor 405 goat anti–mouse IgG, Alexa Fluor 488 goat anti–chicken or anti–
rabbit IgG, and Alexa Fluor 594 goat anti–rabbit IgG (Invitrogen).
DNA constructs
A 2.4-kb DNA fragment containing the full-length coding region of 
rat GAD65 was released from a rat GAD65 cDNA clone (provided by 
A. Tobin, University of California, Los Angeles, Los Angeles, CA) by EcoRI 
restriction digestion and was inserted into the EcoRI site of the eukaryotic 
expression vector pMT2 (Invitrogen). A deletion mutant of rat GAD65 lack-
ing aa 1–38 and having the palmitoylation site, cysteine 45, mutated to 
alanine (rGAD65/45A1-38) in the SV40-based expression vector pSV-
SPORT was described previously (Shi et al., 1994). Human GAD65 with 
aa 24–31 mutated to alanine (hGAD65(24-31A)) was subcloned from 
Bluescript SK into pSV-SPORT at the EcoRI–NarI sites. Full-length cDNA for 
human GAD67 in the Bluescript KS vector (a gift from A. Tobin) was sub-
cloned into the pSV-SPORT vector. Full-length cDNA for mouse GAD67 in 
Bluescript II SK± (a gift from R. Tisch, University of North Carolina at Chapel 
Hill, Chapel Hill, NC) was subcloned into the SalI site of the pSV-SPORT 
vector as described previously (Kanaani et al., 1999). The C-terminal fu-
sion proteins of EGFP and mouse or human GAD67 were generated by 
PCR using mouse or human GAD67 in pSV-SPORT as templates. The PCR 
products were subcloned into the HindIII and KpnI sites in-frame with EGFP in 
pEGFP-N3 (Takara Bio Inc.). Full-length rat GAD67 cDNA in Bluescript SK+ 
(a gift from D. Gottlieb, Washington University, St. Louis, MO; Wyborski, 
et al., 1990) was subcloned into a pSV-SPORT vector at the EcoRI–HindIII 
site. The C-terminal fusion protein of EGFP and rat GAD67 was generated 
by PCR using rat GAD67 in pSV-SPORT as template. The PCR product was 
subcloned into the HindIII and KpnI sites in-frame with EGFP in pEGFP-N3. 
Sequencing of the resulting clone rat GAD67-GFP revealed single nucleotide 
mutations, resulting in a proline instead of leucine in position 102 and a 
leucine instead of valine in position 473. This construct was renamed rat 
GAD67(L102P, V473L)-GFP or rat GAD67(L102P)-GFP for short. Both muta-
tions were also present in the original rat GAD67 cDNA in the Bluescript 
SK+ vector. Targeted mutagenesis to correct the L102P and V473L muta-
tions in the rat GAD67-GFP fusion, and to create a corresponding L103P 
mutation in the human GAD67-GFP construct and a L102P mutation in the 
mouse GAD67-GFP construct, was performed using the QuikChange XL Site-
Directed Mutagenesis kit (Agilent Technologies). Sequencing was used to 
confirm the mutated constructs. The construction of the C-terminal fusion pro-
tein of EGFP and human GAD65 was described previously (Kanaani et al., 
2002). The mammalian expression vector containing mCherry-tagged wt 
human GAD65 fusion protein (hGAD65-mCherry) was prepared by replac-
ing EGFP with mCherry in hGAD65-EGFP in the pEGFP-N3 mammalian ex-
pression vector. The mCherry tag was prepared by PCR amplification using 
the N-terminal primer containing a BamHI restriction site and the C-terminal 
primer containing a NotI restriction site, and using pRSETB-mCherry (a gift 
from R. Tsien, University of California, San Diego, San Diego, CA; Shaner 
et al., 2004) as a template. The amplification product of mCherry was gel 
purified, digested with the restriction endonuclease BamHI and NotI, and 
ligated into a similarly digested pEGFP-N3, which expresses the EGFP fusion 
protein of GAD65.
Cell culture and transfection
Primary hippocampal neuronal cultures were prepared from embryonic 
day 18/19 rats according to previously published protocols (Brewer et al., 
1993). Hippocampal cultures were transfected at day in vitro 6–7 using 
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was centrifuged at 800 g for 10 min to remove nuclei and cellular debris. 
The postnuclear supernatant was centrifuged at 150,000 g for 1 h in a TLA 
100.3 rotor using a tabletop ultracentrifuge (Beckman Coulter) to separate 
cytosol and crude membrane fractions. Sedimented membranes were washed 
twice by resuspension in 0.5 ml of membrane washing buffer (HMAP buf-
fer containing 0.5 M NaCl) and incubation for 1 h, followed by ultracen-
trifugation at 150,000 g for 1 h to pellet the washed membranes. Washed 
membranes were extracted for 1 h with 0.5 ml of extraction buffer (HMAP 
buffer containing 150 mM NaCl and 1% Triton X-114) followed by centrifu-
gation for 1 h at 150,000 g to separate particulate extract from insoluble 
debris. For immunoblotting, proteins from each fraction were resolved by 
SDS-PAGE, transferred to nitrocellulose membranes, and probed with either 
the 1701 rabbit antiserum and HRP-labeled goat anti–rabbit IgG (Southern-
Biotech) or the mouse monoclonal antibody to GFP (Babco) and HRP-labeled 
sheep anti–mouse IgG (GE Healthcare). Labeled bands were visualized 
using the ECL plus Western blotting detection system (Ge Healthcare). Blots 
were quantified using National Institutes of Health Image software (http://rsb 
.info.nih.gov/nih-image/).
Computational modeling of the L102P mutation
Lacking an atomic level 3D model of mouse or rat GAD67, we used the 
crystal structure of human GAD67 deposited in the Protein Data Bank 
(accession no. 2OKJ) to model the mutation by means of energy refine-
ment. In this crystal structure, the leucine 103 residue of human GAD67 is 
the homologue of leucine 102 in rat and mouse GAD67. Residues 1–92 
are missing. Computationally, energy refinement is highly demanding if all 
the remainder of GAD67 is used as a context of residue 103. Preliminary 
modeling was therefore devoted to determining the size of the homo-
dimeric segment that begins with residue 93 of monomers A and B, includes 
residue 103, and can absorb the local change in conformation induced by 
the replacement of leucine 103 with a proline. In addition, the residues of 
the local environment with which proline in position 103 would likely inter-
act were determined. Beginning with segment a93–a106, from monomer 
A and containing the substituted proline, it was refined in isolation under 
the constraint that its C-terminal residue be held fixed. This constraint serves 
to model the segment a93–a106 as being attached to the rest of GAD67 
and otherwise determine its local interactive environment. Subsequently, 
the segment a93–a119 was found to be satisfactory and its potential inter-
active local environment was determined to consist of segments a163–
a169 from monomer A and b195–b198, b573–b574, b132, and b470 
from monomer B. The assembly of these five environmental segments and 
segment a93–a119 thus became the object of energy refinement subject to 
the constraints that residues a116–119 be fixed as well as the backbone 
of the environmental segments. Fixing backbones permits the side chains to 
actively interact with the primary segment a93–a119 but otherwise remain 
fixed and thus represent the rest of GAD67.
The InsightII molecular modeling program (Accelrys, Inc.) was used 
for the modeling. With AMBER as the force field and a dielectric constant 
of 10, energy refinement consisted of 3,000 steps of conjugate gradient 
energy minimization, followed by 5 picoseconds of dynamics, and then 
a repeat of the same energy minimization. The root mean square energy 
gradient achieved in both cases of minimization was <0.001. Not using 
all of GAD67 in our reduced model requires accounting for the isolation 
of the primary segment 93–119. Refinement of the chosen assembly was 
therefore first done without mutating the primary segment to give a control 
against which changes in conformation of the mutated segment could be 
compared. The mutation was then implemented by replacing leucine 103 
in the control segment with a proline and then applying energy refinement 
to the corresponding assembly. A very important aspect of this subsequent 
energy refinement is that the first energy minimization application resulted 
in a conformation that was not too different from that of the control seg-
ment, and thus showed that the mutated segment had a locally stable con-
formation that would probably not result in a significant reorientation of the 
missing segment 1–92. Applying the 5-picosecond dynamics simulation 
followed by the energy minimization did, however, result in a much differ-
ent, locally stable conformation for the mutated segment, which was sig-
nificantly more stable than the initial one, in that the energy of the mutated 
assembly was 10% lower than that of the nonmutated one. It is this confor-
mation, with regard to the mutated segment, that is shown in Fig. S2.
Online supplemental material
Fig. S1 shows that the K2 rabbit polyclonal antibody is specific for GAD67, 
whereas the GAD6 monoclonal antibody is specific for GAD65 in immuno-
fluorescence analyses of rat hippocampal neurons. Fig. S2 shows modeled 
changes in the structure of the human GAD67 dimer caused by a L103P 
the Effectene lipid-mediated gene transfer kit (QIAGEN). After 2–3 h of 
incubation at 37°C, the transfection solution was replaced with a 50:50 
solution of fresh/conditioned medium. For indirect immunofluorescence 
analyses, MDCK, COS-7, and CHO-K1 cells were cultured on poly-d-lysine–
pretreated glass coverslips in 24-well plates. MDCK cells were maintained 
in MEM containing Earle’s salts and supplemented with 10% fetal calf serum, 
25 µM glutamine, and penicillin/streptomycin. COS-7 cells were maintained 
in DME supplemented with 10% fetal calf serum, 2 mM glutamine, and 
penicillin/streptomycin. CHO-K1 cells were maintained in F-12K medium 
supplemented with 10% fetal calf serum, 2 mM glutamine, and penicillin/
streptomycin. COS-7 and CHO-K1 cells were transfected using Lipofectamine 
Plus reagent, and MDCK cells were transfected using Lipofectamine 2000 
reagent according to the manufacturer’s instructions (Invitrogen). After 
5 h of incubation at 37°C, the transfection solution was replaced with fresh 
culture medium.
Immunofluorescence analyses and quantification
For indirect immunofluorescence, neuronal cultures were fixed for 48–72 h 
after transfection with either 3.7% PFA in PBS, pH 7.4, for 15 min or in 
methanol (20°C) for 10 min (staining for synaptophysin). MDCK cells 
were fixed 24–48 h after transfection with 3.7% PFA. A chicken poly-
clonal anti-GFP antibody (Millipore) and a Living Colors DsRed rabbit 
polyclonal antibody, which was raised against DsRed-Express and recog-
nizes mCherry, were used as primary antibodies to enhance the signal of 
GFP and mCherry chimeras, respectively, in neuronal and nonneuronal 
transfections. After fixation, cells were washed with PBS and blocked for 
20 min with blocking solution (2% normal goat serum and 0.3% Triton 
X-100 in PBS). Cells were incubated with primary antibodies in block-
ing solution for 1 h at room temperature, followed by incubation with the 
appropriate fluorochrome-conjugated secondary antibodies in blocking 
solution for 1 h at room temperature. Coverslips were then mounted on 
slides (Frost Plus; Thermo Fisher Scientific) with Fluoromount-G (Southern-
Biotech). Nuclear staining was achieved by mounting the coverslips on 
slides with a mixture of Fluoromount-G and Vectashield mounting medium 
with DAPI (Vector Laboratories). Fluorescent images were acquired with 
either a TCS NT laser scanning confocal microscope (Leica) with a krypton- 
argon and UV lasers, or TCS SL or TCS SP2 laser scanning confocal micro-
scopes (Leica) equipped with acousto-optical beam splitters and an HCX 
Plan-Apochromat 63×/1.20 NA oil objective (Leica). Images of 8-bit depth 
were collected using the Leica confocal software and were prepared for 
presentation with Photoshop (Adobe). All confocal images represent projec-
tions derived from 8–10 consecutive horizontal optical sections estimated 
at 0.2–0.5 µm in thickness.
For analysis of the number of axonal puncta for mouse and rat 
GAD67-GFP in rat hippocampal neurons, images were taken at equal 
exposure times to cover the whole neuronal cell and then were combined 
using Photoshop. MetaMorph imaging software (Universal Imaging Corp.) 
was used to determine the number of puncta detected after thresholding 
the image. The threshold was set to be twice the axonal background. For 
multichannel imaging, fluorescent dyes were imaged sequentially in frame-
interlace mode to eliminate cross talk between the channels. Quantification 
of the number of mouse, rat, or human GAD67-GFP–containing vesicles 
in the cytosol of transfected COS-7 cells was performed manually on pro-
jected confocal images of COS-7 cells using Openlab software (Perkin-
Elmer). The number of vesicles was counted in an area of 50–70 µm2 and 
was repeated five times per cell for a total of five cells per condition. The 
results were expressed as the number of vesicles per 10 µm2. Results of 
quantification were analyzed by a t test using a two-tailed distribution and 
two-sample equal variance.
Detergent extraction, subcellular fractionation, and immunoblotting
Detergent extraction with 1% Triton X-114 and subcellular fractionation of 
COS-7 cells was performed as described previously (Kanaani et al., 1999). 
Transfected COS-7 cells, grown to 80–90% confluency in a 10-cm plate, 
were washed twice in ice-cold cell harvesting buffer (20 mM Hepes/NaOH, 
pH 7.4, 150 mM NaCl, and 10 mM benzamidine/HCl). For detergent ex-
traction, washed cells were incubated on a shaker for 1 h at 4°C in 0.5 ml 
of hypotonic Hepes buffer (HMAP buffer; 10 mM Hepes/NaOH, pH 7.4, 
1 mM MgCl2, 1 mM 2-aminoethylisothiouronium bromide, 0.2 mM PLP, 5 mM 
EDTA, 0.1 mM p-chloromercuriphenyl sulfonic acid, 1 µg/ml leupeptin, 
1 mM phenylmethylsulfonyl fluoride, 10 mM benzamidine, 0.1 mM Na3VO4, 
5 mM NaF, and 5 mM N-ethylmaleimide) containing 1% Triton X-114. The 
lysate was centrifuged at 150,000 g for 30 min to remove insoluble de-
bris. For subcellular fractionation, washed cells were homogenized on ice 
using a glass homogenizer with 0.5 ml of HMAP buffer. The homogenate 
JCB • VOLUME 190 • NUMBER 5 • 2010 924
Duncan, J.A., and A.G. Gilman. 1998. A cytoplasmic acyl-protein thioester-
ase that removes palmitate from G protein alpha subunits and p21(RAS).  
J. Biol. Chem. 273:15830–15837. doi:10.1074/jbc.273.25.15830
Fenalti, G., R.H. Law, A.M. Buckle, C. Langendorf, K. Tuck, C.J. Rosado, N.G. 
Faux, K. Mahmood, C.S. Hampe, J.P. Banga, et al. 2007. GABA produc-
tion by glutamic acid decarboxylase is regulated by a dynamic catalytic 
loop. Nat. Struct. Mol. Biol. 14:280–286. doi:10.1038/nsmb1228
Hensch, T.K., M. Fagiolini, N. Mataga, M.P. Stryker, S. Baekkeskov, and S.F. 
Kash. 1998. Local GABA circuit control of experience-dependent plas-
ticity in developing visual cortex. Science. 282:1504–1508. doi:10.1126/ 
science.282.5393.1504
Jin, H., H. Wu, G. Osterhaus, J. Wei, K. Davis, D. Sha, E. Floor, C.C. Hsu, R.D. 
Kopke, and J.Y. Wu. 2003. Demonstration of functional coupling between 
gamma-aminobutyric acid (GABA) synthesis and vesicular GABA trans-
port into synaptic vesicles. Proc. Natl. Acad. Sci. USA. 100:4293–4298. 
doi:10.1073/pnas.0730698100
Kanaani, J., D. Lissin, S.F. Kash, and S. Baekkeskov. 1999. The hydrophilic 
isoform of glutamate decarboxylase, GAD67, is targeted to membranes 
and nerve terminals independent of dimerization with the hydrophobic 
membrane-anchored isoform, GAD65. J. Biol. Chem. 274:37200–37209. 
doi:10.1074/jbc.274.52.37200
Kanaani, J., Ael.-D. el-Husseini, A. Aguilera-Moreno, J.M. Diacovo, D.S. Bredt, 
and S. Baekkeskov. 2002. A combination of three distinct trafficking 
signals mediates axonal targeting and presynaptic clustering of GAD65. 
J. Cell Biol. 158:1229–1238. doi:10.1083/jcb.200205053
Kanaani, J., M.J. Diacovo, Ael.-D. El-Husseini, D.S. Bredt, and S. Baekkeskov. 
2004. Palmitoylation controls trafficking of GAD65 from Golgi mem-
branes to axon-specific endosomes and a Rab5a-dependent pathway to 
presynaptic clusters. J. Cell Sci. 117:2001–2013. doi:10.1242/jcs.01030
Kanaani, J., G. Patterson, F. Schaufele, J. Lippincott-Schwartz, and S. Baekkeskov. 
2008. A palmitoylation cycle dynamically regulates partitioning of the 
GABA-synthesizing enzyme GAD65 between ER-Golgi and post-Golgi 
membranes. J. Cell Sci. 121:437–449. doi:10.1242/jcs.011916
Kash, S.F., R.S. Johnson, L.H. Tecott, J.L. Noebels, R.D. Mayfield, D. Hanahan, 
and S. Baekkeskov. 1997. Epilepsy in mice deficient in the 65-kDa 
isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA. 
94:14060–14065. doi:10.1073/pnas.94.25.14060
Kash, S.F., L.H. Tecott, C. Hodge, and S. Baekkeskov. 1999. Increased anxiety 
and altered responses to anxiolytics in mice deficient in the 65-kDa 
isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA. 
96:1698–1703. doi:10.1073/pnas.96.4.1698
Kim, J., W. Richter, H.-J. Aanstoot, Y. Shi, Q. Fu, R. Rajotte, G. Warnock, and 
S. Baekkeskov. 1993. Differential expression of GAD65 and GAD67 
in human, rat, and mouse pancreatic islets. Diabetes. 42:1799–1808. 
doi:10.2337/diabetes.42.12.1799
Kim, S.J., Z. Zhang, C. Sarkar, P.C. Tsai, Y.C. Lee, L. Dye, and A.B. Mukherjee. 
2008. Palmitoyl protein thioesterase-1 deficiency impairs synaptic vesicle 
recycling at nerve terminals, contributing to neuropathology in humans 
and mice. J. Clin. Invest. 118:3075–3086. doi:10.1172/JCI33482
Obata, K., T. Fukuda, S. Konishi, F.Y. Ji, H. Mitoma, and T. Kosaka. 1999. 
Synaptic localization of the 67,000 mol. wt isoform of glutamate de-
carboxylase and transmitter function of GABA in the mouse cerebel-
lum lacking the 65,000 mol. wt isoform. Neuroscience. 93:1475–1482. 
doi:10.1016/S0306-4522(99)00274-2
Owens, D.F., and A.R. Kriegstein. 2002a. Developmental neurotransmitters? 
Neuron. 36:989–991. doi:10.1016/S0896-6273(02)01136-4
Owens, D.F., and A.R. Kriegstein. 2002b. Is there more to GABA than synaptic 
inhibition? Nat. Rev. Neurosci. 3:715–727. doi:10.1038/nrn919
Patel, A.B., R.A. de Graaf, D.L. Martin, G. Battaglioli, and K.L. Behar. 2006. 
Evidence that GAD65 mediates increased GABA synthesis during in-
tense neuronal activity in vivo. J. Neurochem. 97:385–396. doi:10.1111/
j.1471-4159.2006.03741.x
Richter, W., Y. Shi, and S. Baekkeskov. 1993. Autoreactive epitopes defined 
by diabetes-associated human monoclonal antibodies are localized 
in the middle and C-terminal domains of the smaller form of gluta-
mate decarboxylase. Proc. Natl. Acad. Sci. USA. 90:2832–2836. doi: 
10.1073/pnas.90.7.2832
Schwartz, H.L., J.M. Chandonia, S.F. Kash, J. Kanaani, E. Tunnell, A. Domingo, 
F.E. Cohen, J.P. Banga, A.M. Madec, W. Richter, and S. Baekkeskov. 
1999. High-resolution autoreactive epitope mapping and structural mod-
eling of the 65 kDa form of human glutamic acid decarboxylase. J. Mol. 
Biol. 287:983–999. doi:10.1006/jmbi.1999.2655
Shaner, N.C., R.E. Campbell, P.A. Steinbach, B.N.G. Giepmans, A.E. Palmer, 
and R.Y. Tsien. 2004. Improved monomeric red, orange and yellow fluores-
cent proteins derived from Discosoma sp. red fluorescent protein. Nat. 
Biotechnol. 22:1567–1572. doi:10.1038/nbt1037
Shi, Y., B. Veit, and S. Baekkeskov. 1994. Amino acid residues 24-31 but not 
palmitoylation of cysteines 30 and 45 are required for membrane anchoring 
mutation. Fig. S3 shows that the GAD65-independent mechanisms of 
GAD67 membrane anchoring are functional in COS-7, MDCK, and CHO 
cells. Fig. S4 shows that in COS-7 cells, the leucine-to-proline mutation 
abolishes targeting of GAD67 to Golgi membranes and cytosolic vesicles 
in the absence of GAD65. Fig. S5 shows that in COS-7 cells, the GAD65-
dependent membrane anchoring of GAD67 is not affected by the L102P 
mutation. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.200912101/DC1.
We thank Roger Tsien, David Gottlieb, Allan Tobin, Ronald Tisch, and Wiltrud 
Richter for reagents.
This study was supported by the Nora Eccles Treadwell Foundation and 
by a National Institutes of Health Diabetes Education and Research Center 
grant (P30 DK063720) Microscopy Core.
Submitted: 16 December 2009
Accepted: 3 August 2010
References
Asada, H., Y. Kawamura, K. Maruyama, H. Kume, R. Ding, F.Y. Ji, N. Kanbara, 
H. Kuzume, M. Sanbo, T. Yagi, and K. Obata. 1996. Mice lacking the 
65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain nor-
mal levels of GAD67 and GABA in their brains but are susceptible to 
seizures. Biochem. Biophys. Res. Commun. 229:891–895. doi:10.1006/ 
bbrc.1996.1898
Asada, H., Y. Kawamura, K. Maruyama, H. Kume, R.G. Ding, N. Kanbara, 
H. Kuzume, M. Sanbo, T. Yagi, and K. Obata. 1997. Cleft palate and 
decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa 
isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA. 
94:6496–6499. doi:10.1073/pnas.94.12.6496
Baekkeskov, S., and J. Kanaani. 2009. Palmitoylation cycles and regulation of 
protein function (Review). Mol. Membr. Biol. 26:42–54. doi:10.1080/ 
09687680802680108
Battaglioli, G.H., H. Liu, and D.L. Martin. 2003. Kinetic differences between 
the isoforms of glutamate decarboxylase: implications for the regulation 
of GABA synthesis. J. Neurochem. 86:879–887. doi:10.1046/j.1471-
4159.2003.01910.x
Brewer, G.J., J.R. Torricelli, E.K. Evege, and P.J. Price. 1993. Optimized sur-
vival of hippocampal neurons in B27-supplemented Neurobasal, a new 
serum-free medium combination. J. Neurosci. Res. 35:567–576. doi: 
10.1002/jnr.490350513
Bu, D.F., M.G. Erlander, B.C. Hitz, N.J. Tillakaratne, D.L. Kaufman, C.B. 
Wagner-McPherson, G.A. Evans, and A.J. Tobin. 1992. Two human 
glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each 
encoded by a single gene. Proc. Natl. Acad. Sci. USA. 89:2115–2119. 
doi:10.1073/pnas.89.6.2115
Capitani, G., D. De Biase, H. Gut, S. Ahmed, and M.G. Grütter. 2005. Structural 
model of human GAD65: prediction and interpretation of biochemi-
cal and immunogenic features. Proteins. 59:7–14. doi:10.1002/prot 
.20372
Chang, Y.C., and D.I. Gottlieb. 1988. Characterization of the proteins purified 
with monoclonal antibodies to glutamic acid decarboxylase. J. Neurosci. 
8:2123–2130.
Chattopadhyaya, B., G. Di Cristo, C.Z. Wu, G. Knott, S. Kuhlman, Y. Fu, R.D. 
Palmiter, and Z.J. Huang. 2007. GAD67-mediated GABA synthesis and 
signaling regulate inhibitory synaptic innervation in the visual cortex. 
Neuron. 54:889–903. doi:10.1016/j.neuron.2007.05.015
Christgau, S., H. Schierbeck, H.J. Aanstoot, L. Aagaard, K. Begley, H. Kofod, K. 
Hejnaes, and S. Baekkeskov. 1991. Pancreatic  cells express two auto-
antigenic forms of glutamic acid decarboxylase, a 65-kDa hydrophilic 
form and a 64-kDa amphiphilic form which can be both membrane-bound 
and soluble. J. Biol. Chem. 266:21257–21264.
Christgau, S., H.J. Aanstoot, H. Schierbeck, K. Begley, S. Tullin, K. Hejnaes, and 
S. Baekkeskov. 1992. Membrane anchoring of the autoantigen GAD65 to 
microvesicles in pancreatic -cells by palmitoylation in the NH2-terminal 
domain. J. Cell Biol. 118:309–320. doi:10.1083/jcb.118.2.309
Condie, B.G., G. Bain, D.I. Gottlieb, and M.R. Capecchi. 1997. Cleft palate in 
mice with a targeted mutation in the gamma-aminobutyric acid-producing 
enzyme glutamic acid decarboxylase 67. Proc. Natl. Acad. Sci. USA. 
94:11451–11455. doi:10.1073/pnas.94.21.11451
Dirkx, R. Jr., A. Thomas, L. Li, A. Lernmark, R.S. Sherwin, P. De Camilli, and 
M. Solimena. 1995. Targeting of the 67-kDa isoform of glutamic acid 
decarboxylase to intracellular organelles is mediated by its interaction 
with the NH2-terminal region of the 65-kDa isoform of glutamic 
acid decarboxylase. J. Biol. Chem. 270:2241–2246. doi:10.1074/jbc 
.270.5.2241
925Targeting of GAD67 to presynaptic clusters • Kanaani et al.
of glutamic acid decarboxylase, GAD65. J. Cell Biol. 124:927–934. 
doi:10.1083/jcb.124.6.927
Shimura, T., U. Watanabe, Y. Yanagawa, and T. Yamamoto. 2004. Altered taste 
function in mice deficient in the 65-kDa isoform of glutamate decarbox-
ylase. Neurosci. Lett. 356:171–174. doi:10.1016/j.neulet.2003.11.041
Soghomonian, J.J., and D.L. Martin. 1998. Two isoforms of glutamate de-
carboxylase: why? Trends Pharmacol. Sci. 19:500–505. doi:10.1016/ 
S0165-6147(98)01270-X
Solimena, M., D. Aggujaro, C. Muntzel, R. Dirkx, M. Butler, P. De Camilli, 
and A. Hayday. 1993. Association of GAD-65, but not of GAD-67, with 
the Golgi complex of transfected Chinese hamster ovary cells mediated 
by the N-terminal region. Proc. Natl. Acad. Sci. USA. 90:3073–3077. 
doi:10.1073/pnas.90.7.3073
Solimena, M., R. Dirkx Jr., M. Radzynski, O. Mundigl, and P. De Camilli. 
1994. A signal located within amino acids 1-27 of GAD65 is required 
for its targeting to the Golgi complex region. J. Cell Biol. 126:331–341. 
doi:10.1083/jcb.126.2.331
Stork, O., F.Y. Ji, K. Kaneko, S. Stork, Y. Yoshinobu, T. Moriya, S. Shibata, and 
K. Obata. 2000. Postnatal development of a GABA deficit and distur-
bance of neural functions in mice lacking GAD65. Brain Res. 865:45–58. 
doi:10.1016/S0006-8993(00)02206-X
Stork, O., H. Yamanaka, S. Stork, N. Kume, and K. Obata. 2003. Altered con-
ditioned fear behavior in glutamate decarboxylase 65 null mutant mice. 
Genes Brain Behav. 2:65–70. doi:10.1034/j.1601-183X.2003.00008.x
Tian, N., C. Petersen, S. Kash, S. Baekkeskov, D. Copenhagen, and R. Nicoll. 
1999. The role of the synthetic enzyme GAD65 in the control of neuro-
nal -aminobutyric acid release. Proc. Natl. Acad. Sci. USA. 96:12911–
12916. doi:10.1073/pnas.96.22.12911
Wang, D.D., and A.R. Kriegstein. 2009. Defining the role of GABA in cortical 
development. J. Physiol. 587:1873–1879.
Wyborski, R.J., R.W. Bond, and D.I. Gottlieb. 1990. Characterization of a cDNA 
coding for rat glutamic acid decarboxylase. Brain Res. Mol. Brain Res. 
8:193–198. doi:10.1016/0169-328X(90)90016-7
